Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desloratadine/Betamethasone vs Desloratadine in Allergic Rhinitis
NCT06916884Phase 3Completed
- Sponsor
- Laboratorios Silanes
- Start
- Nov 2024
- Primary completion
- Oct 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of betamethasone in allergic rhinitis (AR), sponsored by Laboratorios Silanes. Started Nov 2024; status: completed.
02
Drugs
betamethasone
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT06916884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06916884.